NP94023a-d Ellipta Inhalers
What the buyer wrote
Supply of Ellipta Inhalers to NHS Scotland: NP94023a: Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Anoro® Ellipta®) NP94023b: Umeclidinium bromide 65micrograms/dose dry powder inhaler (Incruse® Ellipta®) NP94023c: Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Relvar® Ellipta®) NP94023c: Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Relvar® Ellipta®) NP94023d: Fluticasone furoate 92micrograms/dose / Umeclidinium 55micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Trelegy® Ellipta®)
Bid for this and lost? There is a short window in which the decision can be questioned.
Details
- What the buyer calls it
- NP94023a-d Ellipta Inhalers
- How they are buying
- Given to one supplier, no competitionNobody else was asked, and the buyer has to be able to justify that.
- Type
- goods
- Framework
- Yes: joining it lets you bid for call-offs without a new tender each time
- Where
- in Scotland
- Kind of work
- Pharmacy and medicines
Who the buyer named
Gordon Ralph was the named contact on this notice.